Spontaneous physical activity in obesity
Spontaneous physical activity in obesity
批准号:
7771733
负责人:
CATHERINE M KOTZ
金额:
$29.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-20 至 2013-01-31
关键词:
AffectAmericanAnimal ModelAnimalsAreaArousalBody WeightBody mass indexBrainDataDevelopmentDiabetes MellitusDiseaseDoseEnvironmentFOS geneFoundationsGoalsHealthHeart DiseasesHumanHypothalamic structureIndividualKnowledgeLeadLifeMediatingNeuromodulatorNeuronsObesityOverweightPeptidesPhysical activityPopulationRattusRegulationRegulatory PathwayRelative (related person)ResearchResistanceRisk FactorsRoleSignal TransductionSiteSprague-Dawley RatsStudy modelsSystemTestingTherapeutic InterventionThermogenesisTimeVariantWeight Gainbasebrain pathwaycancer typeenergy balancehypocretinobesity treatmentobesogenicorexin Apublic health relevancereceptorreceptor expressionrelating to nervous system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Obesity and overweight affects most Americans, but there are some who resist obesity, just as some animals resist obesity. Animal and human studies indicate that spontaneous physical activity (SPA), which generates nonexercise activity thermogenesis (NEAT), is an important defense against weight gain. Brain mechanisms control the level SPA, and the NEAT so generated, but the specifics are undefined. We propose that hypothalamic orexin A (OxA) is an important part of the SPA regulatory pathway, and that sensitivity to OxA signals enhancing SPA and NEAT helps determine propensity for obesity. The objectives of this application are to test the following hypotheses: (1) elevated OxA mediated SPA protects against weight gain and (2) increased OxA-mediated SPA in obesity resistant (OR) rats results from increased orexin receptor expression. Our long-range goal is to use knowledge of SPA and NEAT regulatory pathways to guide therapeutic interventions on these mechanisms among obese humans. We plan 3 aims: Aim 1) Characterize orexin neuron subpopulations important to SPA. A) Are there strain differences in orexin message and peptide in subpopulations of orexin neurons? B) Does destruction of subpopulations of orexin neurons affect SPA? Aim 2) Determine importance of OxA-mediated SPA to weight gain. A) Does reduced OxA action in rLH of OR rats reduce resistance to weight gain? B) Does SPA induced by high dose OxA stimulation of rLH reduce weight gain in OP rats? Aim 3) Verify that increased orexin sensitivity in OR rats is due to increased orexin receptor expression. A) Is orexin receptor number increased in OR compared to OP rats? B) Is c-fos activation in rLH orexin receptor bearing neurons higher in OR than OP rats? C) Does reducing orexin receptor bearing neurons in rLH of OR rats enhance weight gain? A greater understanding of brain orexin and its relationship to SPA in obesity will fill a large gap in knowledge of centrally mediated SPA and NEAT, and its importance to obesity resistance. PUBLIC HEALTH RELEVANCE The current proposal is aimed at understanding the role of a specific brain pathway that controls physical activity, which is important to body weight regulation. Obesity is a major health problem affecting at least one third of the U.S. population, and is a risk factor for several diseases, including heart disease, diabetes and several types of cancer. Underlying part of the problem is disordered regulation of physical activity, and a better understanding of the brain pathways important to this is necessary in developing treatments for obesity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reducing the post weight-loss energy expenditure gap with orexin agonists
-
批准号:10745184
-
项目类别:
-
资助金额:$73.1万
-
财政年份:2023
-
负责人:CATHERINE M KOTZ
-
依托单位:
Orexin agonists as novel obesity therapeutics
-
批准号:10655285
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:CATHERINE M KOTZ
-
依托单位:
Fisetin as a treatment for community-acquired pathogen susceptibility during aging, obesity and neurodegenerative diseases
-
批准号:10610378
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:CATHERINE M KOTZ
-
依托单位:
Fisetin as a treatment for community-acquired pathogen susceptibility during aging, obesity and neurodegenerative diseases
-
批准号:10425193
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:CATHERINE M KOTZ
-
依托单位:
Orexin agonists as novel obesity therapeutics
-
批准号:10369478
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:CATHERINE M KOTZ
-
依托单位:
ShEEP Request for Acquisition of Sable Promethion Caging
-
批准号:9213046
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:CATHERINE M KOTZ
-
依托单位:
Role of Variability in SPA in Susceptibility to Obesity
-
批准号:8728499
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2014
-
负责人:CATHERINE M KOTZ
-
依托单位:
Role of Variability in SPA in Susceptibility to Obesity
-
批准号:9211311
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2014
-
负责人:CATHERINE M KOTZ
-
依托单位:
Role of Variability in SPA in Susceptibility to Obesity
-
批准号:8998020
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2014
-
负责人:CATHERINE M KOTZ
-
依托单位:
Minnesota Obesity Prevention Training (MnOPT)
-
批准号:10407386
-
项目类别:
-
资助金额:$8.34万
-
财政年份:2010
-
负责人:CATHERINE M KOTZ
-
依托单位:
Minnesota Obesity Prevention Training (MnOPT)
-
批准号:10612873
-
项目类别:
-
资助金额:$36.78万
-
财政年份:2010
-
负责人:CATHERINE M KOTZ
-
依托单位:
Minnesota Obesity Prevention Training (MnOPT)
-
批准号:10393521
-
项目类别:
-
资助金额:$39.74万
-
财政年份:2010
-
负责人:CATHERINE M KOTZ
-
依托单位:
Minnesota Obesity Prevention Training (MnOPT)
-
批准号:10529962
-
项目类别:
-
资助金额:$8.76万
-
财政年份:2010
-
负责人:CATHERINE M KOTZ
-
依托单位:
Spontaneous Physical Activity in Obesity
-
批准号:8265923
-
项目类别:
-
资助金额:$26.58万
-
财政年份:2009
-
负责人:CATHERINE M KOTZ
-
依托单位:
Spontaneous physical activity in obesity
-
批准号:7580790
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2009
-
负责人:CATHERINE M KOTZ
-
依托单位:
Spontaneous physical activity in obesity
-
批准号:8019437
-
项目类别:
-
资助金额:$33.11万
-
财政年份:2009
-
负责人:CATHERINE M KOTZ
-
依托单位:
Spontaneous physical activity in obesity
-
批准号:7850116
-
项目类别:
-
资助金额:$3.1万
-
财政年份:2009
-
负责人:CATHERINE M KOTZ
-
依托单位:
Spontaneous physical activity in obesity
-
批准号:8090722
-
项目类别:
-
资助金额:$6.71万
-
财政年份:2009
-
负责人:CATHERINE M KOTZ
-
依托单位:
HYPOTHALAMIC HYPOCRETIN PATHWAYS MODULATING FEEDING
-
批准号:6419152
-
项目类别:
-
资助金额:$3.16万
-
财政年份:2000
-
负责人:CATHERINE M KOTZ
-
依托单位:
HYPOTHALAMIC HYPOCRETIN PATHWAYS MODULATING FEEDING
-
批准号:6733210
-
项目类别:
-
资助金额:$3.21万
-
财政年份:2000
-
负责人:CATHERINE M KOTZ
-
依托单位:
海外基金